enzh-TWfrdeitjaptrues

We are excited to announce this new webcast focusing on the experience of patients undergoing treatment for hematologic malignancies during the COVID-19 era.

This on-demand activity, the fifth in a seven-part series, features a discussion on approaches to limit patient and provider exposure to SARS-CoV-2 while effectively managing hematologic malignancies during the COVID-19 pandemic.

Learning Objectives:
Upon successful completion of this educational activity, participants should be better able to:

  • Describe the epidemiology, pathology and current treatment strategies of COVID-19
  • Develop approaches to limit patient and provider exposure to SARS-CoV-2 while effectively managing hematologic malignancies
  • Evaluate current COVID-19 treatment strategies for potential interactions with anticancer agents
  • Identify, mitigate, and manage current and prospective diagnostic, therapeutic, and monitoring challenges in oncology care due to the reallocation of health resources as a result of the COVID-19 pandemic

https://www.naccme.com/program/20-hemcovid-5